Logo image of HDSN

HUDSON TECHNOLOGIES INC (HDSN) Stock Fundamental Analysis

NASDAQ:HDSN - Nasdaq - US4441441098 - Common Stock - Currency: USD

9.78  -0.1 (-1.01%)

After market: 9.78 0 (0%)

Fundamental Rating

5

Overall HDSN gets a fundamental rating of 5 out of 10. We evaluated HDSN against 48 industry peers in the Trading Companies & Distributors industry. While HDSN has a great health rating, its profitability is only average at the moment. HDSN has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

HDSN had positive earnings in the past year.
HDSN had a positive operating cash flow in the past year.
Of the past 5 years HDSN 4 years were profitable.
HDSN had a positive operating cash flow in 4 of the past 5 years.
HDSN Yearly Net Income VS EBIT VS OCF VS FCFHDSN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of 5.72%, HDSN is in line with its industry, outperforming 58.33% of the companies in the same industry.
HDSN's Return On Equity of 7.13% is in line compared to the rest of the industry. HDSN outperforms 41.67% of its industry peers.
With a Return On Invested Capital value of 5.60%, HDSN perfoms like the industry average, outperforming 45.83% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for HDSN is significantly above the industry average of 9.84%.
The last Return On Invested Capital (5.60%) for HDSN is well below the 3 year average (26.20%), which needs to be investigated, but indicates that HDSN had better years and this may not be a problem.
Industry RankSector Rank
ROA 5.72%
ROE 7.13%
ROIC 5.6%
ROA(3y)21.25%
ROA(5y)15.1%
ROE(3y)30.7%
ROE(5y)24.97%
ROIC(3y)26.2%
ROIC(5y)20.28%
HDSN Yearly ROA, ROE, ROICHDSN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60 -80

1.3 Margins

HDSN's Profit Margin of 8.08% is fine compared to the rest of the industry. HDSN outperforms 72.92% of its industry peers.
HDSN's Profit Margin has declined in the last couple of years.
HDSN has a better Operating Margin (8.69%) than 64.58% of its industry peers.
In the last couple of years the Operating Margin of HDSN has declined.
HDSN's Gross Margin of 25.18% is on the low side compared to the rest of the industry. HDSN is outperformed by 66.67% of its industry peers.
HDSN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.69%
PM (TTM) 8.08%
GM 25.18%
OM growth 3Y-17.43%
OM growth 5YN/A
PM growth 3Y-15.02%
PM growth 5YN/A
GM growth 3Y-9.36%
GM growth 5Y21.17%
HDSN Yearly Profit, Operating, Gross MarginsHDSN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), HDSN is creating value.
Compared to 1 year ago, HDSN has less shares outstanding
HDSN has more shares outstanding than it did 5 years ago.
There is no outstanding debt for HDSN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HDSN Yearly Shares OutstandingHDSN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
HDSN Yearly Total Debt VS Total AssetsHDSN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

HDSN has an Altman-Z score of 6.24. This indicates that HDSN is financially healthy and has little risk of bankruptcy at the moment.
HDSN has a better Altman-Z score (6.24) than 85.42% of its industry peers.
There is no outstanding debt for HDSN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.24
ROIC/WACC0.57
WACC9.82%
HDSN Yearly LT Debt VS Equity VS FCFHDSN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

A Current Ratio of 3.88 indicates that HDSN has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.88, HDSN belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
HDSN has a Quick Ratio of 2.46. This indicates that HDSN is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.46, HDSN belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.88
Quick Ratio 2.46
HDSN Yearly Current Assets VS Current LiabilitesHDSN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

HDSN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -51.22%.
Measured over the past years, HDSN shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -10.44% on average per year.
The Revenue for HDSN has decreased by -14.17% in the past year. This is quite bad
Measured over the past years, HDSN shows a small growth in Revenue. The Revenue has been growing by 7.90% on average per year.
EPS 1Y (TTM)-51.22%
EPS 3Y-10.44%
EPS 5YN/A
EPS Q2Q%15%
Revenue 1Y (TTM)-14.17%
Revenue growth 3Y7.16%
Revenue growth 5Y7.9%
Sales Q2Q%-3.23%

3.2 Future

HDSN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.52% yearly.
The Revenue is expected to grow by 2.44% on average over the next years.
EPS Next Y-20.7%
EPS Next 2Y7.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.78%
Revenue Next 2Y2.44%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HDSN Yearly Revenue VS EstimatesHDSN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
HDSN Yearly EPS VS EstimatesHDSN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 24.45 indicates a rather expensive valuation of HDSN.
HDSN's Price/Earnings ratio is in line with the industry average.
HDSN is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.54, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 16.59, which indicates a correct valuation of HDSN.
Based on the Price/Forward Earnings ratio, HDSN is valued a bit cheaper than 68.75% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of HDSN to the average of the S&P500 Index (35.28), we can say HDSN is valued rather cheaply.
Industry RankSector Rank
PE 24.45
Fwd PE 16.59
HDSN Price Earnings VS Forward Price EarningsHDSN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HDSN is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, HDSN is valued cheaper than 97.92% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.4
EV/EBITDA 13.26
HDSN Per share dataHDSN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.52%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for HDSN!.
Industry RankSector Rank
Dividend Yield N/A

HUDSON TECHNOLOGIES INC

NASDAQ:HDSN (8/7/2025, 8:00:01 PM)

After market: 9.78 0 (0%)

9.78

-0.1 (-1.01%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)07-30 2025-07-30/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners79.98%
Inst Owner Change0.81%
Ins Owners12.47%
Ins Owner Change0.2%
Market Cap425.23M
Analysts80
Price Target10.07 (2.97%)
Short Float %4.07%
Short Ratio4.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)25.44%
Min EPS beat(2)17.65%
Max EPS beat(2)33.23%
EPS beat(4)3
Avg EPS beat(4)-108.01%
Min EPS beat(4)-488.23%
Max EPS beat(4)33.23%
EPS beat(8)5
Avg EPS beat(8)-56.22%
EPS beat(12)9
Avg EPS beat(12)-19.66%
EPS beat(16)13
Avg EPS beat(16)51.89%
Revenue beat(2)1
Avg Revenue beat(2)1.77%
Min Revenue beat(2)-0.34%
Max Revenue beat(2)3.87%
Revenue beat(4)1
Avg Revenue beat(4)-3.78%
Min Revenue beat(4)-10.52%
Max Revenue beat(4)3.87%
Revenue beat(8)3
Avg Revenue beat(8)-2.88%
Revenue beat(12)5
Avg Revenue beat(12)-0.02%
Revenue beat(16)8
Avg Revenue beat(16)5.75%
PT rev (1m)0%
PT rev (3m)17.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.31%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.45%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.11%
Valuation
Industry RankSector Rank
PE 24.45
Fwd PE 16.59
P/S 1.89
P/FCF 6.4
P/OCF 5.94
P/B 1.67
P/tB 2.36
EV/EBITDA 13.26
EPS(TTM)0.4
EY4.09%
EPS(NY)0.59
Fwd EY6.03%
FCF(TTM)1.53
FCFY15.63%
OCF(TTM)1.65
OCFY16.82%
SpS5.17
BVpS5.86
TBVpS4.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.72%
ROE 7.13%
ROCE 7.42%
ROIC 5.6%
ROICexc 8.25%
ROICexgc 14.17%
OM 8.69%
PM (TTM) 8.08%
GM 25.18%
FCFM 29.56%
ROA(3y)21.25%
ROA(5y)15.1%
ROE(3y)30.7%
ROE(5y)24.97%
ROIC(3y)26.2%
ROIC(5y)20.28%
ROICexc(3y)28.13%
ROICexc(5y)21.53%
ROICexgc(3y)41.04%
ROICexgc(5y)33.11%
ROCE(3y)34.71%
ROCE(5y)27.37%
ROICexcg growth 3Y-15.43%
ROICexcg growth 5YN/A
ROICexc growth 3Y-15.17%
ROICexc growth 5YN/A
OM growth 3Y-17.43%
OM growth 5YN/A
PM growth 3Y-15.02%
PM growth 5YN/A
GM growth 3Y-9.36%
GM growth 5Y21.17%
F-Score5
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 78.16%
Cap/Sales 2.26%
Interest Coverage 30.75
Cash Conversion 274.77%
Profit Quality 365.8%
Current Ratio 3.88
Quick Ratio 2.46
Altman-Z 6.24
F-Score5
WACC9.82%
ROIC/WACC0.57
Cap/Depr(3y)68.73%
Cap/Depr(5y)52.28%
Cap/Sales(3y)1.53%
Cap/Sales(5y)1.32%
Profit Quality(3y)172.31%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.22%
EPS 3Y-10.44%
EPS 5YN/A
EPS Q2Q%15%
EPS Next Y-20.7%
EPS Next 2Y7.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.17%
Revenue growth 3Y7.16%
Revenue growth 5Y7.9%
Sales Q2Q%-3.23%
Revenue Next Year-3.78%
Revenue Next 2Y2.44%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-63.44%
EBIT growth 3Y-11.52%
EBIT growth 5YN/A
EBIT Next Year-1.03%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y42.85%
FCF growth 3YN/A
FCF growth 5Y21.4%
OCF growth 1Y42.52%
OCF growth 3YN/A
OCF growth 5Y22.11%